You can buy or sell GWPH and other stocks, options, ETFs, and crypto commission-free!
GW Pharmaceuticals Plc American Depositary Shares, also called GW Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. Read More The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.
52 Week High
52 Week Low
Research And Development
How Cannabis is Going 'Greener'
HENDERSON, NV / ACCESSWIRE / March 21, 2019 / The electricity consumption of cannabis grow houses is staggering when compared to business and residential use.
GW Pharmaceuticals PLC (GWPH) Gains As Market Dips: What You Should Know
GW Pharmaceuticals PLC (GWPH) closed the most recent trading day at $170.27, moving +1.28% from the previous trading session. GW Pharmaceuticals PLC (GWPH) closed the most recent trading day at $170.27, moving +1.28% from the previous trading session. This change outpaced the S&P 500's 0.29% loss on the day. At the same time, the Dow lost 0.55%, and the tech-heavy Nasdaq gained 0.07%. Prior to today's trading, shares of the company had gained 11.95% over the past month. This has outpaced the Medical secto...
Expected May 7, After Hours